Jane Street
PPCB

Jane Street’s Propanc Biopharma PPCB Stock Holding History

Jane Street’s Portfolio PPCB Stock Details PPCB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.2K Buy
+5,728
New +$34K ﹤0.01% 11242

Other funds holding PPCB

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Jane Street's PPCB Position: Q1 2026 in Review

Jane Street opened a new position in Propanc Biopharma (PPCB) in Q1 2026: 5,728 shares worth $15.2K. The stake represents ﹤0.01% of the portfolio and ranks #11242 among its holdings.

6 funds tracked by Wall St. Rank hold PPCB as of Q1 2026.

  • Jane Street held 5,728 shares of Propanc Biopharma worth $15.2K as of Q1 2026.
  • Propanc Biopharma was a new Jane Street position in Q1 2026.
  • Propanc Biopharma made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #11242 holding.
  • 6 funds tracked by Wall St. Rank held Propanc Biopharma as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.